Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
11/2007
11/08/2007US20070259932 Benzimidazole derivatives, their production and use
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/07/2007EP1852129A1 Remedy for irritable bowel syndrome
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/06/2007US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
11/06/2007US7291623 Compounds that interact with kinases
11/01/2007WO2007124351A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007054965A3 Process for preparation of tetrazoles from aromatic cyano derivatives
11/01/2007WO2007001684A3 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007CA2649845A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007CA2649628A1 Pharmaceutical product
10/2007
10/31/2007EP1849777A1 Process for obtaining a valsartan salt useful for obtaining valsartan
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065366A Dibenzyl amine compounds and derivatives
10/30/2007US7288571 Thyroid receptor ligands and method II
10/25/2007WO2007119246A2 An improved process for the manufacture of losartan potassium
10/25/2007WO2007088558A3 A process for purification of valsartan
10/25/2007US20070249839 Process for the Preparation of Losartan Potassium Form I
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007DE102006018345A1 Aufhell- und/oder Färbemittel mit Amidinen Reducing and / or coloring with amidines
10/24/2007EP1847524A1 Terphenyl derivatives for treatment of Alzheimer's disease
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN100344617C Chemical synthesizing method of tetrazole compound
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/18/2007US20070244316 Optically pure and enriched isomers of chelating ligands and contrast agents
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244170 Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244082 Anticancer Agent
10/17/2007EP1845093A1 A new crystalline and stable form of andolast
10/17/2007EP1844025A1 Process for preparing amorphous valsartan
10/17/2007EP1844019A2 Methode for the production of losartan
10/17/2007EP1064254B1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
10/16/2007US7282609 Process for production of 1-aryl-5-(trifluoromethyl)-1H-tetrazoles
10/16/2007US7282592 Resorcinol derivatives
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007US20070238882 Process for Preparing Nitrooxy Esters, Nitrooxy Thioesters Nitrooxy Carbonates and Nitrooxy Thiocarbinates, Intermediates Useful in Said Process and Preparation Thereof
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/10/2007EP1841504A2 Substituted biaryl compounds as factor xia inhibitors
10/10/2007CA2579333A1 A new crystalline and stable form of andolast
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/03/2007EP1838681A2 Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
10/03/2007EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007CN101045712A Synthesis method of valsartan
09/2007
09/27/2007US20070225496 Process for preparing temozolomide
09/27/2007US20070225493 Combining CL-20 organic solvent, nonsolvent to form a crystallization solution; saturating the crystallization solution;heating the crystallization solution to a temperature of from about 71 degrees C. to about 94 degrees C.; removing the at least one organic solvent and nonsolvent; separation
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/26/2007CN100339080C Antiviral compounds
09/20/2007WO2007106546A2 Metal complexes of tetraazamacrocycle derivatives
09/20/2007WO2007105050A1 Dibenzyl amine compounds and derivatives
09/20/2007WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents
09/20/2007WO2007057919A3 An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/20/2007CA2717249A1 Dibenzyl amine compounds and derivatives
09/20/2007CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007CA2645668A1 Metal complexes of tetraazamacrocycle derivatives
09/19/2007CN100338050C Amine acid salt compounds and process for the production thereof
09/18/2007US7271269 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
09/13/2007WO2007103456A2 Piperazine and piperidine biaryl derivatives
09/13/2007US20070213371 Dibenzyl Amine Compounds and Derivatives
09/13/2007US20070213329 Sulphones which modulate the action of gammasecretase
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831186A1 A process for the synthesis of valsartan
09/12/2007EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
09/12/2007EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/11/2007US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes
09/11/2007US7267994 For detecting and analyzing oxidized polypeptides, nucleic acids, lipids, and polysaccharides; kits; neurodegenerative/neoplastic/vascular/autoimmune disorders
09/05/2007EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof
09/05/2007EP1828162A1 Tetrazolyl-methylene amino acid derivatives
09/05/2007EP1828092A1 Process and intermediate compounds useful in the preparation of statins
09/05/2007CN101031562A Imidazole-5-carboxylic acid derivative, its production and use
09/05/2007CN100335478C Chemokine receptor binding heterocyclic compounds
09/05/2007CN100335461C Arylsulfonanilide ureas
08/2007
08/30/2007WO2006127503A3 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
08/30/2007US20070203338 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
08/30/2007US20070202047 Polyamine-substituted ligands for use as contrast agents
08/23/2007US20070197549 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007EP1820795A1 Novel anthranilic acid derivative or salt thereof
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/16/2007WO2007091616A1 Metal complex and use thereof
08/16/2007US20070189969 Perfluoroalkyl-containing complexes, process for their production as well as their use
08/16/2007CA2642030A1 Metal complex and use thereof
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 97